ImpoPharma

ImpoPharma, Inc. is a pharmaceutical company focused on research and development, specializing in nasal and pulmonary products. The company offers a variety of drug delivery systems, including dry powder inhalers, metered nasal sprays, metered sublingual sprays, injectable products, ophthalmic products, and oral formulations. Additionally, ImpoPharma provides an array of topical products such as creams, gels, solutions, and suspensions, along with otic products. Its services encompass formulation development for both generic and innovative products, analytical testing, production process development, and clinical trial management support. The company also assists with regulatory submissions and delivery device design, ensuring compliance with various health authorities. Founded in 1996 and based in Concord, Canada, ImpoPharma operates as a subsidiary of Rubicon Research Canada Limited.